Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) NonCurrent Deferred Revenue: ₫0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

STC:DBD Binh Dinh Pharmaceutical And Medical Equipment JSC STC:DBD
80 GF Score
Price ₫49,200.00
GF Value ₫52,290.30
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Binh Dinh Pharmaceutical And Medical Equipment JSC NonCurrent Deferred Revenue?

Binh Dinh Pharmaceutical And Medical Equipment JSC STC:DBD 80 NonCurrent Deferred Revenue is ₫0 Mil as of Jun. 2026. GuruFocus rates STC:DBD with a GF Score™ of 80/100 and a GF Value™ of ₫52,290.30 (Fairly Valued). The stock has 4 warning signs investors should review.

Non-Current Deferred Revenue represents the non-current portion of deferred revenue amount as of the balance sheet date. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months.

Binh Dinh Pharmaceutical And Medical Equipment JSC's non-current deferred revenue for the quarter that ended in Jun. 2026 was ₫0 Mil.

Binh Dinh Pharmaceutical And Medical Equipment JSC NonCurrent Deferred Revenue Related Terms

Binh Dinh Pharmaceutical And Medical Equipment JSC NonCurrent Deferred Revenue Historical Data

* Premium members only.

The historical data trend for Binh Dinh Pharmaceutical And Medical Equipment JSC's NonCurrent Deferred Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Binh Dinh Pharmaceutical And Medical Equipment JSC NonCurrent Deferred Revenue Chart

Binh Dinh Pharmaceutical And Medical Equipment JSC Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
NonCurrent Deferred Revenue
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Binh Dinh Pharmaceutical And Medical Equipment JSC Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
NonCurrent Deferred Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
STC:DBD
80GF Score
Binh Dinh Pharmaceutical And Medical Equipment JSC STC:DBD
NonCurrent Deferred Revenue is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis
What does a NonCurrent Deferred Revenue of ₫0 Mil mean?
Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) has a NonCurrent Deferred Revenue of ₫0 Mil as of Jun. 2026. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC's NonCurrent Deferred Revenue too high?
Binh Dinh Pharmaceutical And Medical Equipment JSC's current NonCurrent Deferred Revenue is ₫0 Mil. Overall, Binh Dinh Pharmaceutical And Medical Equipment JSC has a GF Score™ of 80/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Binh Dinh Pharmaceutical And Medical Equipment JSC's NonCurrent Deferred Revenue compare to ZTS?
Binh Dinh Pharmaceutical And Medical Equipment JSC's NonCurrent Deferred Revenue of ₫0 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good NonCurrent Deferred Revenue for a Drug Manufacturers company?
A good NonCurrent Deferred Revenue depends on the Drug Manufacturers industry context. However, NonCurrent Deferred Revenue should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high NonCurrent Deferred Revenue mean?
A high NonCurrent Deferred Revenue can signal that a stock is expensive relative to its fundamentals. Deferred revenue is a liability related to revenue producing activity for which revenue has not yet been recognized and is not expected be recognized in the next twelve months. View historical data on Binh Dinh Pharmaceutical And Medical Equipment JSC and its competitors. Binh Dinh Pharmaceutical And Medical Equipment JSC's current NonCurrent Deferred Revenue is ₫0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Binh Dinh Pharmaceutical And Medical Equipment JSC stock overvalued right now?
Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) is currently considered Fairly Valued. The stock's GF Value™ is ₫52,290.30, compared to a current price of ₫49,200.00 — trading 5.9% below its estimated fair value. The current NonCurrent Deferred Revenue is ₫0 Mil. Binh Dinh Pharmaceutical And Medical Equipment JSC's overall GF Score™ is 80/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is NonCurrent Deferred Revenue calculated?
NonCurrent Deferred Revenue is calculated from a company's financial statements. For Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD), the current NonCurrent Deferred Revenue is ₫0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Binh Dinh Pharmaceutical And Medical Equipment JSC (STC:DBD) Overvalued in 2026?

Based on GuruFocus' analysis, Binh Dinh Pharmaceutical And Medical Equipment JSC stock appears to be undervalued. The current stock price of ₫49,200.00 is trading 5.9% below its estimated GF Value™ of ₫52,290.30. GuruFocus considers Binh Dinh Pharmaceutical And Medical Equipment JSC to be Fairly Valued.

Key valuation signals for STC:DBD:

  • NonCurrent Deferred Revenue: ₫0 Mil
  • GF Value™: ₫52,290.30 vs. price of ₫49,200.00 (5.9% below fair value)
  • GF Score™: 80/100 with 4 warning signs

No single metric tells the full story. See the STC:DBD stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Binh Dinh Pharmaceutical And Medical Equipment JSC Business Description

Address 498 Nguyen Thai Hoc Street, Quang Trung Ward, Binh Dinh Province, Quy Nhon, VNM
Binh Dinh Pharmaceutical And Medical Equipment JSC is a pharmaceutical company. The company is engaged in production and trade of pharmaceutical products, medicinal herbs, pharmaceutical and medical equipment.
80GF Score

Get the complete analysis for STC:DBD

NonCurrent Deferred Revenue is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₫49,200.00
Price
₫52,290.30
GF Value